Advertisement
Screener

SANUWAVE Health, Inc. (SNWV) Overview

SANUWAVE Health, Inc. (SNWV) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.08; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.17; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.39; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.04; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$3.80$6.17$10.02$16.26$26.40$42.862025-09-292026-09-29$3.80$6.29$10.41$17.24$28.54$47.252024-10-182026-09-29$3.80$6.29$10.41$17.24$28.54$47.252024-10-182026-09-29$3.80$6.29$10.41$17.24$28.54$47.252024-10-182026-09-29$3.80$6.29$10.41$17.24$28.54$47.252024-10-182026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$4.74
Previous close
$4.65
Change
$0.09
Change (%)
1.94%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

SNWV
-84.12%
S&P 500
(m)

1 year

SNWV
-86.30%
S&P 500
(m)

3 years

SNWV
(m)
S&P 500
(m)

5 years

SNWV
(m)
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.08

-0.80-0.46-0.110.230.5731 Mar 2025: estimate (m); actual -0.7231 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.0430 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.3930 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.1731 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0830 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.08(m)(m)
1 Jan 202631 Mar 2026(m)-0.17(m)(m)
1 Jul 202530 Sept 2025(m)0.39(m)(m)
1 Apr 202530 Jun 2025(m)-0.04(m)(m)
1 Jan 202531 Mar 2025(m)-0.72(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.41

-12.27-9.05-5.84-2.630.5931 Dec 2021: estimate (m); actual -0.0531 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.0231 Dec 2022(m)31 Dec 2023: estimate (m); actual -12.1931 Dec 2023(m)31 Dec 2024: estimate (m); actual -7.4131 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.4131 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.41(m)(m)
1 Jan 202431 Dec 2024(m)-7.41(m)(m)
1 Jan 202331 Dec 2023(m)-12.19(m)(m)
1 Jan 202231 Dec 2022(m)-0.02(m)(m)
1 Jan 202131 Dec 2021(m)-0.05(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 9.74M ■ Earnings -0.68M — Profit margin -7.00%

-2.98M-16.0%2.33M18.0%7.65M51.9%12.97M85.8%30 Jun 2025: revenue 10.15M; earnings 0.55M; profit margin 5.43%30 Jun 202530 Sept 2025: revenue 11.42M; earnings 9.69M; profit margin 84.82%30 Sept 202531 Mar 2026: revenue 9.62M; earnings -1.44M; profit margin -14.96%31 Mar 202630 Jun 2026: revenue 9.74M; earnings -0.68M; profit margin -7.00%30 Jun 2026

31 Dec 2025 ■ Revenue 44.05M ■ Earnings 11.81M — Profit margin 26.82%

-42.34M-135.0%-10.46M-80.7%21.43M-26.5%53.31M27.8%31 Dec 2022: revenue 15.51M; earnings -10.29M; profit margin -66.36%31 Dec 202231 Dec 2023: revenue 19.25M; earnings -25.81M; profit margin -134.03%31 Dec 202331 Dec 2024: revenue 32.33M; earnings -33.08M; profit margin -102.33%31 Dec 202431 Dec 2025: revenue 44.05M; earnings 11.81M; profit margin 26.82%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$4.74(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$4.74High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning SNWV

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-12; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$15.26M
Profit margin
34.70%
Return on assets · 12 month
43.82%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
57.80K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
2.16%*
Total return · month
1.39%*
Total return · quarter
-51.88%*
Total return · half year
-74.53%*
Total return · year to date
-84.12%*
Total return · 1 year
-86.30%*
Total return · 3 years
(m)
Total return · 5 years
(m)
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$43.97M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

SANUWAVE Health, Inc. Overview

View more →

(m)

(m)

SEC CIK
1417663
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
9600 W. 76TH STREET, EDEN PRAIRIE, Minnesota, United States
Fiscal year end
1231
Phone
952-656-1029

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEPHROS INC (NEPH)United States$0.046B23.02
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24
InspireMD, Inc. (NSPR)$0.033B
PAVmed Inc. (PAVM)United States$0.031B-3.00
Spectral AI, Inc. (MDAI)United States$0.052B
Xtant Medical Holdings, Inc. (XTNT)United States$0.053B
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
TELA Bio, Inc. (TELA)United States$0.057B-0.82
HeartBeam, Inc. (BEAT)United States$0.022B-2.08